- Home
- SGMO vs MGF Comparison
SGMO vs MGF Comparison
Compare SGMO & MGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- MGF
- Stock Information
- Founded
- SGMO 1995
- MGF 1987
- Country
- SGMO United States
- MGF United States
- Employees
- SGMO N/A
- MGF N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- MGF Trusts Except Educational Religious and Charitable
- Sector
- SGMO Health Care
- MGF Finance
- Exchange
- SGMO Nasdaq
- MGF Nasdaq
- Market Cap
- SGMO 122.8M
- MGF 101.0M
- IPO Year
- SGMO 2000
- MGF N/A
- Fundamental
- Price
- SGMO $0.64
- MGF $3.07
- Analyst Decision
- SGMO Strong Buy
- MGF
- Analyst Count
- SGMO 7
- MGF 0
- Target Price
- SGMO $5.29
- MGF N/A
- AVG Volume (30 Days)
- SGMO 4.9M
- MGF 104.4K
- Earning Date
- SGMO 11-11-2025
- MGF 01-01-0001
- Dividend Yield
- SGMO N/A
- MGF 7.64%
- EPS Growth
- SGMO N/A
- MGF N/A
- EPS
- SGMO N/A
- MGF N/A
- Revenue
- SGMO $81,706,000.00
- MGF N/A
- Revenue This Year
- SGMO $28.47
- MGF N/A
- Revenue Next Year
- SGMO N/A
- MGF N/A
- P/E Ratio
- SGMO N/A
- MGF N/A
- Revenue Growth
- SGMO 565.52
- MGF N/A
- 52 Week Low
- SGMO $0.41
- MGF $2.91
- 52 Week High
- SGMO $3.18
- MGF $3.46
- Technical
- Relative Strength Index (RSI)
- SGMO 49.82
- MGF 45.27
- Support Level
- SGMO $0.62
- MGF $3.04
- Resistance Level
- SGMO $0.69
- MGF $3.10
- Average True Range (ATR)
- SGMO 0.05
- MGF 0.02
- MACD
- SGMO -0.01
- MGF -0.00
- Stochastic Oscillator
- SGMO 25.77
- MGF 50.00
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About MGF MFS Government Markets Income Trust
MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.